 |
 |
 |
|
The Effect of Food on the Pharmacokinetics of
Unboosted and Boosted Tenofovir Alafenamide
|
|
|
IDSA: Lack of Drug Interactions Between Boosted and Unboosted TAF-Based Antiretroviral Single-Tablet Regimens (E/C/F/TAF, R/F/TAF) and the anti-HCV Single-Tablet Regimen Ledipasvir/Sofosbuvir (10/13/15)
Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain
Joseph M. Custodio, Yongwu Shao, Xuelian Wei, Amanda Vu, Martin Rhee, Marshall Fordyce, Brian P. Kearney, Julia Z. Zack
Gilead Sciences, Inc., Foster City, California, USA






|
|
|
 |
 |
|
|